Neuropharmacology 2018, 136: 271279
PlexusDx Precision Peptide Genetic Test analyzes how your body responds to GLP-1 receptor activation and identifies genetic variants like GLP1R rs6923761 that influence appetite suppression sensitivity
In effect, this dual GLP-1 + GIP agonist can improve fat cell metabolic flexibility
[13] [14] By activating these three pathways together, retatrutide is thought to produce effects on appetite suppression and blood glucose regulation
More recently, innovative molecules like the dual glucose-dependent insulinotropic polypeptide and the glucagon-like peptide 1 (GLP1R-GIPR) receptors agonists, such as tirzepatide, have shown even greater efficacy, with weight loss up to 18% [21]
Common tests include HbA1c to evaluate blood sugar control, fasting glucose, comprehensive metabolic panel (kidney and liver function), lipid panel, and thyroid function tests